
SMS Pharmaceuticals Ltd
NSE:SMSPHARMA

Intrinsic Value
The intrinsic value of one
SMSPHARMA
stock under the Base Case scenario is
164.36
INR.
Compared to the current market price of 256.97 INR,
SMS Pharmaceuticals Ltd
is
Overvalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
SMS Pharmaceuticals Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
SMS Pharmaceuticals Ltd
Balance Sheet Decomposition
SMS Pharmaceuticals Ltd
Current Assets | 5.8B |
Cash & Short-Term Investments | 207.3m |
Receivables | 2.1B |
Other Current Assets | 3.5B |
Non-Current Assets | 5.5B |
Long-Term Investments | 165.9m |
PP&E | 5.2B |
Intangibles | 24.6m |
Other Non-Current Assets | 153.3m |
Free Cash Flow Analysis
SMS Pharmaceuticals Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
SMS Pharmaceuticals Ltd
Revenue
|
7.8B
INR
|
Cost of Revenue
|
-5.3B
INR
|
Gross Profit
|
2.5B
INR
|
Operating Expenses
|
-1.5B
INR
|
Operating Income
|
981.9m
INR
|
Other Expenses
|
-320.9m
INR
|
Net Income
|
661m
INR
|
SMSPHARMA Profitability Score
Profitability Due Diligence
SMS Pharmaceuticals Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Score
SMS Pharmaceuticals Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
SMSPHARMA Solvency Score
Solvency Due Diligence
SMS Pharmaceuticals Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Score
SMS Pharmaceuticals Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SMSPHARMA Price Targets Summary
SMS Pharmaceuticals Ltd
Dividends
Current shareholder yield for SMSPHARMA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SMSPHARMA
stock under the Base Case scenario is
164.36
INR.
Compared to the current market price of 256.97 INR,
SMS Pharmaceuticals Ltd
is
Overvalued by 36%.